D-Wave Has Many Positive Attributes, But There’s a Better Name in the Quantum Sector

D-Wave, a prominent quantum firm (QBTS), possesses numerous positive attributes, including promising technologies, rapidly growing bookings, a substantial U.S. government investment, and an impressive list of customers. However, Quantinuum (QNT), backed by major owner Honeywell (HON), also exhibits these qualities. Quantinuum's revenue, backlog, and cash reserves significantly surpass those of D-Wave, rendering it a more secure choice for investors at present.

Canada-based investment bank BMO Capital has shown confidence in D-Wave due to its dual annealing and gate-model systems. BMO anticipates a $450 billion to $850 billion addressable market for D-Wave based on Boston Consulting Group's projections, attributing this to the firm's ability to handle various quantum applications. BMO has set a $35 price target and rated D-Wave stock as "Outperform."

D-Wave's bookings soared 1,120% in the first half of the year, reaching $35.5 million, while its remaining performance obligations climbed 668% year-over-year to $40.7 million. The company received a $100 million investment from Washington in May. Major customers include Toyota, Deloitte, Mastercard, and Volkswagen, with $546 million in cash reserves as of June 30th.

Quantinuum, on the other hand, is making substantial strides in the pharmaceutical and medical sectors. The firm displayed, alongside NVIDIA and a Fortune 100 pharmaceutical company, the potential benefits of AI-driven quantum simulation in molecular property characterization for pharmaceutical applications. Quantinuum has also developed a new parallel quantum phase-estimation algorithm, which can expedite and improve molecular property determination, useful in pharmaceuticals, life sciences, and energy. Additionally, Quantinuum is working on enhancing Magnetic Resonance Imaging (MRI) technology.

As of August 11th, Quantinuum had $81 million in bookings since January 1st, and its RPO reached $74 million by the end of Q2. Notably, Quantinuum generated $8 million in revenue for Q2, significantly higher than D-Wave's $3.1 million. Prominent Quantinuum customers include JPMorgan, Airbus, HSBC, and BMW, with $74 million in RPO as of June 30th.

Unlike D-Wave, Quantinuum has secured a $100 million investment from Washington and boasts a cash reserve of $2.1 billion, providing it with the financial flexibility to invest more in R&D and acquire impactful assets while minimizing the need to dilute shareholders.